Monash IVF Chief Executive Michael Knaap has resigned following the company’s second high-profile embryo error in recent months, prompting the appointment of Chief Financial Officer Malik Jainudeen as acting CEO.
In a statement to the ASX, the company said it “respects” Knaap’s decision to step down, acknowledging his leadership since 2019 during a period of “significant growth and transformation.”